Lynn M. Georgic

570 total citations
14 papers, 484 citations indexed

About

Lynn M. Georgic is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Lynn M. Georgic has authored 14 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 3 papers in Organic Chemistry. Recurrent topics in Lynn M. Georgic's work include Receptor Mechanisms and Signaling (10 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Neuropeptides and Animal Physiology (5 papers). Lynn M. Georgic is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Neuropeptides and Animal Physiology (5 papers). Lynn M. Georgic collaborates with scholars based in United States. Lynn M. Georgic's co-authors include Robert G. MacKenzie, Hyacinth C. Akunne, Thomas A. Pugsley, Steven Z. Whetzel, M. Duff Davis, James G. Granneman, Lawrence D. Wise, Thomas G. Heffner, G. Damsma and Shelly A. Glase and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Lynn M. Georgic

14 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynn M. Georgic United States	9	337	337	65	49	44	14	484
Stephan Hjorth Sweden	15	272 0.8×	346 1.0×	44 0.7×	75 1.5×	44 1.0×	22	540
Keith R. Jarvie Canada	14	512 1.5×	528 1.6×	46 0.7×	40 0.8×	56 1.3×	22	749
Anne Dumbrille-Ross Canada	14	348 1.0×	335 1.0×	111 1.7×	51 1.0×	54 1.2×	16	555
M Assumpció Boronat Spain	9	307 0.9×	404 1.2×	144 2.2×	47 1.0×	14 0.3×	10	572
Susanne R. Haadsma‐Svensson United States	9	278 0.8×	323 1.0×	26 0.4×	95 1.9×	45 1.0×	15	458
Bernard J. Van Vliet Netherlands	15	362 1.1×	428 1.3×	64 1.0×	79 1.6×	26 0.6×	23	587
Robert N. Cory France	9	331 1.0×	315 0.9×	92 1.4×	44 0.9×	17 0.4×	10	515
Michael A. Olsen United States	7	509 1.5×	484 1.4×	79 1.2×	49 1.0×	105 2.4×	10	743
A. Cordi France	10	200 0.6×	207 0.6×	37 0.6×	60 1.2×	26 0.6×	15	365
Carole A. Wilmot United States	11	160 0.5×	270 0.8×	87 1.3×	43 0.9×	107 2.4×	16	466

Countries citing papers authored by Lynn M. Georgic

Since Specialization

Citations

This map shows the geographic impact of Lynn M. Georgic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn M. Georgic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn M. Georgic more than expected).

Fields of papers citing papers by Lynn M. Georgic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn M. Georgic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn M. Georgic. The network helps show where Lynn M. Georgic may publish in the future.

Co-authorship network of co-authors of Lynn M. Georgic

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn M. Georgic. A scholar is included among the top collaborators of Lynn M. Georgic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn M. Georgic. Lynn M. Georgic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Akunne, Hyacinth C., Kim Zoski, M. Duff Davis, et al.. (2000). PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. I. Neurochemical effects. Neuropharmacology. 39(7). 1197–1210. 5 indexed citations

Belliotti, Thomas R., David J. Wustrow, Kim Zoski, et al.. (1999). A Series of 6- and 7-Piperazinyl- and -Piperidinylmethylbenzoxazinones with Dopamine D4 Antagonist Activity: Discovery of a Potential Atypical Antipsychotic Agent. Journal of Medicinal Chemistry. 42(25). 5181–5187. 19 indexed citations

Wustrow, David J., Thomas R. Belliotti, Shelly A. Glase, et al.. (1998). Aminopyrimidines with High Affinity for Both Serotonin and Dopamine Receptors. Journal of Medicinal Chemistry. 41(5). 760–771. 25 indexed citations

Whetzel, Steven Z., et al.. (1997). Effects of the Dopamine D₃ Antagonist PD 58491 and Its Interaction with the Dopamine D₃ Agonist PD 128907 on Brain Dopamine Synthesis in Rat. Journal of Neurochemistry. 69(6). 2363–2368. 13 indexed citations

Belliotti, Thomas R., Suzanne R. Kesten, John R. Rubin, et al.. (1997). Novel cyclohexyl amides as potent and selective D3 dopamine receptor ligands. Bioorganic & Medicinal Chemistry Letters. 7(18). 2403–2408. 15 indexed citations

Glase, Shelly A., Hyacinth C. Akunne, Lynn M. Georgic, et al.. (1997). Substituted [(4-Phenylpiperazinyl)- methyl]benzamides: Selective Dopamine D₄ Agonists. Journal of Medicinal Chemistry. 40(12). 1771–1772. 93 indexed citations

Wustrow, David J., William Smith, Ann E. Corbin, et al.. (1997). 3-[[(4-Aryl-1-piperazinyl)alkyl]cyclohexyl]-1H-indoles as Dopamine D2 Partial Agonists and Autoreceptor Agonists. Journal of Medicinal Chemistry. 40(2). 250–259. 8 indexed citations

Wright, Jon L., Gary L. Bolton, Dennis M. Downing, et al.. (1996). ChemInform Abstract: 8‐Amino‐6‐(arylsulfonyl)‐5‐nitroquinolines: Novel Nonpeptide Neuropeptide Y1 Receptor Antagonists.. ChemInform. 27(49). 1 indexed citations

Wright, Jon L., Gary L. Bolton, Dennis M. Downing, et al.. (1996). 8-amino-6-(arylsulphonyl)-5-nitroquinolines: novel nonpeptide neuropeptide Y1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 6(15). 1809–1814. 23 indexed citations

10.

Pugsley, Thomas A., M. Duff Davis, Hyacinth C. Akunne, et al.. (1995). Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.. Journal of Pharmacology and Experimental Therapeutics. 275(3). 1355–1366. 176 indexed citations

11.

Davis, M. Duff, et al.. (1995). CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.. Journal of Pharmacology and Experimental Therapeutics. 274(2). 898–911. 2 indexed citations

12.

Pugsley, Thomas A., M. Duff Davis, Hyacinth C. Akunne, et al.. (1995). CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.. PubMed. 274(2). 898–911. 12 indexed citations

13.

MacKenzie, Robert G., et al.. (1994). Differential interaction of β1- and β3-adrenergic receptors with Gi in rat adipocytes. Cellular Signalling. 6(4). 457–465. 88 indexed citations

14.

Wustrow, David J., Lawrence D. Wise, Robert G. MacKenzie, et al.. (1994). Studies of the Active Conformation of a Novel Series of Benzamide Dopamine D2 Agonists. Journal of Medicinal Chemistry. 37(24). 4251–4257. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact